Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Regulatory and Compliance Updates news
(page 20)
20 November 2025
DOMO Chemicals Achieves EcoVadis Platinum Rating with Improved Score
DOMO improved its EcoVadis score by 33 points, excelling in environment, labor, ethics, and procurement, reflecting its commitment to sustainable practices and responsible business.
20 November 2025
EnWG Draft Changes Essential for Biomethane Expansion
The EnWG draft risks undermining biomethane's role in Germany's energy transition, threatening production, infrastructure, and investment security.
19 November 2025
Terumo Aortic Launches Fenestrated TREO® IDE Study in US
The study evaluates endovascular repair of aortic aneurysms using the Fenestrated TREO® System, enrolling 210 patients across 45 US sites, with a 5-year follow-up.
19 November 2025
TotalEnergies Boosts Stake in Nigeria's OPL257
TotalEnergies acquires 50% of OPL257 from Conoil, increasing its stake to 90%. Conoil gains 40% in OML136. The deal supports Egina South field development. Completion awaits approvals.
19 November 2025
Merck's KEYTRUDA® Subcutaneous Form Approved by European Commission
KEYTRUDA SC, a subcutaneous immune checkpoint inhibitor, is approved in Europe for faster administration across all adult indications.
19 November 2025
Merck Reports Positive Phase 3 Trial Results for HIV-1 Treatment DOR/ISL
DOR/ISL shows non-inferiority to BIC/FTC/TAF in HIV-1 treatment-naïve adults, meeting efficacy and safety goals. Detailed findings to be presented at a future scientific congress.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
19 November 2025
BASF Expands Biomass-Balanced Methanol Certification with ISCC EU
BASF's methanol now meets four sustainability certifications, aiding chemical and biofuel sectors in reducing fossil use and achieving sustainability goals.
19 November 2025
Roche's Lunsumio SC Approved in EU for Relapsed Follicular Lymphoma
Lunsumio SC offers quick administration for relapsed follicular lymphoma, reducing treatment time to one minute with proven efficacy and safety.
18 November 2025
Genmab's EPKINLY Combination Approved by FDA for Relapsed Follicular Lymphoma
EPKINLY + R² shows superior progression-free survival and response rates in Phase 3 trial for relapsed follicular lymphoma, with a consistent safety profile.
18 November 2025
EU Imposes Safeguard Measures on Ferroalloy Imports; Impact on Elkem
The EU enacts tariff rate quotas on ferroalloy imports, effective Nov 2025 for three years, excluding silicon metal. Elkem anticipates sales shifts and potential price increases.
18 November 2025
ORLEN's Baltic East Wind Farm Secures Environmental Approval
Baltic East project advances with environmental approval, enabling participation in Poland's first offshore wind auction, aiming for 1 GW capacity and strong local supplier involvement.
18 November 2025
TotalEnergies Responds to French Competition Authority's Decision on Corsica
TotalEnergies disputes a fine over Corsica fuel supply, citing lack of evidence and plans to appeal, while reviewing its operations on the island.
18 November 2025
Roche's Giredestrant Shows Superior Survival in Early Breast Cancer
Giredestrant shows significant benefit in early-stage ER-positive, HER2-negative breast cancer, with positive trends in overall survival and a favorable safety profile.
17 November 2025
Carbon Centric Achieves FSSC 22000 for Food Grade CO₂ Production
Rakkestad plant certified for food grade CO₂ with 99.99% purity, supporting future storage and e-fuel applications.
17 November 2025
Eastman: Regional Recycling Key to Circularity Success
Regional recycling is vital for EU's circularity. Local waste should meet recycled content targets to retain investments and jobs. Urgent action is needed to address industry challenges.
13 November 2025
EnviTec Biogas and TT-Line Partner for Bio-LNG Supply
TT-Line's Peter Pan successfully bunkers 40 tons of bio-LNG, advancing sustainable maritime transport under EU regulations for reduced greenhouse gas emissions.
11 November 2025
Ercros Reports EUR 4M EBITDA, EUR 41M Losses
Weak demand, high energy costs, and competition impact results. Cost reduction plan on track. Solid liquidity. Awaiting EU support. Bondalti takeover bid approved with conditions.
11 November 2025
BASF and Beyond Suncare Applaud WHO's Inclusion of Sunscreen as Essential Medicine
WHO lists broad-spectrum sunscreen as essential, boosting access and affordability, especially for vulnerable groups like those with albinism.
10 November 2025
Rompetrol Rafinare's Ecological Rehabilitation of Vega Refinery Lagoons
The project neutralizes emissions, protects water, and restores ecosystems, using efficient treatment to transform acidic tars into inert waste, ensuring compliance with environmental standards.
10 November 2025
Boehringer Ingelheim's Zongertinib Receives FDA Priority Voucher for HER2-Mutant NSCLC
Zongertinib gains FDA's Priority Voucher, expediting review for HER2-mutant NSCLC treatment. A supplemental New Drug Application is planned for first-line use.
10 November 2025
Novo Nordisk: Wegovy® Shows Liver Health Benefits Beyond Weight Loss in MASH Patients
Semaglutide 2.4 mg improves liver health in MASH patients, showing benefits across weight loss levels and diverse demographics, according to ESSENCE trial data.
10 November 2025
Roche's Fenebrutinib Shows Promising Phase III Results for Multiple Sclerosis
Fenebrutinib reduces relapses in RMS and slows disability in PPMS, showing potential as a high-efficacy oral treatment. Full data expected by 2026 for regulatory submission.
9 November 2025
Merck's Enlicitide Decanoate Cuts LDL-C in HeFH Patients in Phase 3 Trial
Enlicitide decanoate shows significant LDL-C reduction in HeFH patients, with a safety profile similar to placebo, in the CORALreef HeFH trial.
7 November 2025
Novamont's Mater-Bi Mulch Film Certified as EU Inorganic Soil Improver
Mater-Bi mulch film is biodegradable, doesn't release microplastics, and meets EU standards, aiding soil health and reducing agricultural plastic waste.
6 November 2025
Boehringer Ingelheim's Apecotrep Reduces Proteinuria in Phase II Kidney Trial
Apecotrep, a TRPC6 inhibitor, showed 40% proteinuria reduction in FSGS patients. Phase III trial recruiting; further Phase II trials planned for other kidney diseases.
6 November 2025
Sasol Develops Methane Rich Gas Solution for South Africa's Post-2028 Gas Supply
Sasol plans to supply Methane Rich Gas from 2028-2030 to bridge South Africa's gas supply gap, pending regulatory approval, while transitioning to LNG for long-term needs.
6 November 2025
Johnson & Johnson's DARZALEX FASPRO®: First FDA-Approved Treatment for High-Risk Smoldering Multiple Myeloma
DARZALEX FASPRO® reduces progression risk to active multiple myeloma by 51% in high-risk patients, marking a shift in treatment strategy.
6 November 2025
Novo Nordisk's CagriSema Reduces Blood Pressure and Inflammation, Lowers Heart Disease Risk
CagriSema shows potential in reducing blood pressure, inflammation, and heart disease risk, with ongoing trials to assess cardiovascular outcomes.
6 November 2025
Novo Nordisk and U.S. Administration to Lower GLP-1 Costs and Expand Access
Novo Nordisk to lower semaglutide prices in 2026, expand Medicare Part D coverage, and expects a slight negative impact on global sales growth.
6 November 2025
Lilly and U.S. Government Expand Access to Obesity Drugs
Medicare beneficiaries to access obesity drugs at $50/month. LillyDirect offers self-pay options. FDA approval pending.
← Previous
Next →
